BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 22171592)

  • 1. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
    Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
    J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
    Li H; Tsui T
    Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
    Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
    Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
    Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
    Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
    Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
    J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell targeting peptide conjugation to siRNA polyplexes for effective gene silencing in cardiomyocytes.
    Nam HY; Kim J; Kim SW; Bull DA
    Mol Pharm; 2012 May; 9(5):1302-9. PubMed ID: 22452378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
    Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
    Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
    Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
    Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and characterization of a new peptide vector for short interfering RNA delivery.
    Chen B; Xu W; Pan R; Chen P
    J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
    Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
    Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
    Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
    J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
    Dohmen C; Wagner E
    Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
    Li H; Zheng X; Koren V; Vashist YK; Tsui TY
    Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
    van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
    ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions.
    Ezzat K; Zaghloul EM; El Andaloussi S; Lehto T; El-Sayed R; Magdy T; Smith CI; Langel U
    J Control Release; 2012 Aug; 162(1):1-8. PubMed ID: 22698942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.